1.Genetically Altered Corn May Cause Diabetes
June 14, 2006
New Zealand's governmental food standards board may approve a genetically altered type of corn used for animal feed. The Monsanto Corporation produces the new corn called High-Lysine Corn LY038.
Monsanto scientists have altered the corn to contain higher levels of the amino acid lysine than is found in other corn varieties.
While lysine itself isn't a health risk, if the LY038 variety is cooked with sugars also found in the corn, compounds called AGE's are produced which are implicated in causing Alzheimer's disease, diabetes, and several other health conditions.
Even though Monsanto states that LY038 is intended only for animal feed, they made application for approval as a human food so they do not have to keep the altered corn separate from edible corn.
The real problem is the government's food agency made no effort to test what the health impact would be if the LY038 were to enter the human food supply. Numerous ways animal feed either can accidentally or deliberately end up eaten by humans is a serious risk.
There are many countries with diabetes epidemics, including New Zealand and the United States. Risking our food supply is not worth the risk of potentially increasing the sugar content of food in a diabetic diet or everyday foods.
2.Food code not grounded on best available science
Press Release: University of Canterbury Centre for Integrated Research in Biosafety
8 June 2006
Proposed change to food code not grounded on best available science
The Centre for Research in Biosafety (INBI) is urging the food standards agency to reconsider its draft recommendation to approve a new type of GM corn.
INBI has recommended that Food Standards Australia New Zealand (FSANZ) should not approve Monsanto's genetically modified high-lysine LY038 corn until further safety studies have been conducted.
FSANZ is the agency responsible for protecting the safety and integrity of food sold in Australia and New Zealand.
Monsanto has applied to FSANZ for LY038 to be permitted in the food supply, but has declared that its intention is to market LY038 as animal feed. INBI believes LY038 is the first genetically modified crop plant substantially different in its nutritional profile to be considered for approval as a human food. INBI recommends that safety studies be conducted using GM corn that has been cooked and processed as it is in human food.
"The key difference between the use of corn as an animal feed and a human food is cooking and processing, and FSANZ has made no attempt to assess food hazards resulting from cooking or processing of LY038," said INBI Director and University of Canterbury Associate Professor Jack Heinemann.
He said LY038 corn was substantially different to conventional corn in that it has high concentrations of compounds that are known to produce food hazards when heated with the sugars found in corn.
"We've carefully examined the risk assessment done by FSANZ and its supporting materials, and we can't understand why FSANZ does not ask for the obvious scientific studies that would establish the safety of this product when it is cooked and processed, the way people - and not chickens - eat it," Heinemann said.
While the FSANZ assessment assumes that LY038 would enter the food supply only in small amounts and inadvertently, the INBI submission identifies a number of realistic pathways, both deliberate and inadvertent, through which the amounts of LY038 in the food supply could be much more significant.
In its submission to FSANZ, INBI makes over 90 major recommendations, most of which identify deficiencies in the supporting scientific studies and in the analysis conducted by FSANZ. INBI also notes ways in which the FSANZ standards deviate from those recommended by international food safety bodies such as Codex Alimentarius and the World Health Organisation.
"FSANZ is obligated to use the best scientific evidence available and conduct a case-by-case assessment. From our point of view, it hasn't consistently done either," said Heinemann. INBI has called on FSANZ to explain how it weighs competing costs and benefits when coming to its decisions.
"FSANZ is charged with maintaining public confidence in the quality and safety of food," said Billie Moore, an INBI researcher. "This is impossible without public confidence in FSANZ and its decision-making processes, which must therefore be transparent and open to public scrutiny and evaluation. It cannot expect the public to have confidence in unsubstantiated assertions and unexplained reasoning." For the INBI submission, please go to: http://www.inbi.canterbury.ac.nz/Documents/submissions/submissionDARA549.pdf
Scientists Say Monsanto's Genetically Engineered Corn May Cause Diabetes
GM WATCH daily, June 15, 2006
Straight to the Source